LT-alpha Mouse Monoclonal Antibody [6-C10-10]
Lymphotoxin-alpha (LTA), a member of the tumor necrosis factor (TNF) family of cytokines, was initially isolated on the basis of an anti-tumor activity. LTA plays a key role in communication between lymphocytes and stromal cells, thereby eliciting cytotoxic effects on cancer cells. It induces the expression of vascular cell-adhesion molecule 1 (VCAM1) on vascular endothelial cells and recruits natural killer (NK) cells to parenchymal organs and tumor lesions.
Product Specifications
CAS Number
9007-83-4
Product Name Alternative
Abbreviation
LT-alpha
Swiss Prot
P01374 Human
Cellular Locus
Secretory
Host
Mouse
Species Reactivity
Human,Rat
Immunogen
Synthetic peptide within Human LT-alpha aa 51-100 / 205.
Isotype
IgG1
Conjugation
Non-conjugated
Type
Mouse monoclonal Antibody
Applications
WB
Positive Control
Recombinant LT-alpha (TNF-β)
Concentration
2 mg/mL
Dilution
ELISA: 1:10,000 WB: 1:500
Purity
Protein A affinity purified.
Form
Liquid
Buffer
1*PBS (pH7.4), 0.2% BSA, 25% Glycerol. Preservative: 0.05% Sodium Azide.
Molecular Weight
18 kDa
Storage Conditions
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Recombinant Antibody
No
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF568 conjugate, 0.1mg/mL
